Q&A – Site and Patient Engagement
CEO Gadi Saarony and Deb Tatton, Parexel Senior Vice President of Global Clinical Operations, consider ways to improve site and patient engagement in this Fireside Chat Q&A blog part 2.
Q&A – The Evolving Role of Technology
In this Fireside Chat Q&A blog , CEO Gadi Saarony and Deb Tatton, Parexel Senior Vice President of Global Clinical Operations, share perspectives on technology's evolving role in clinical research.
From Reactive to Proactive: How to Evolve Your Research Program During a Global Crisis
Many research programs are evaluating how to keep research moving forward in the face of critical staff shortages and budget limitations—during the COVID-19 pandemic and beyond. Sites are busier than…
Institutional Perspectives: Leveraging Technology to Meet Operational Goals During COVID-19
The COVID-19 pandemic ushered in a myriad of changes for clinical research professionals. One of the most impactful has been the immediate shift to remote processes to accommodate both research…
Fireside Chat: The Future of Clinical Trials and Site Engagement
The COVID-19 pandemic has proven that research can be done more efficiently. To make these efficiencies sustainable, the sites’ perspective must be considered. Sponsors, CROs, and sites should engage early…
Introducing Fireside Chats: Conversations On Burning Research Topics
Advarra is excited to introduce Fireside Chats, a series of virtual conversations discussing current issues in clinical trials. Each Fireside Chat brings together perspectives from across the research community, enabling…
COVID-19 Lessons Learned: Technology and Agility in the New Clinical Trial Landscape
Clinical trials research was forced to evolve and embrace technology in the wake of the COVID-19 pandemic. This unprecedented crisis created a necessary disruption in the use of technology to…
Q&A Part 1 – Evaluating Payment to Participate in Research: Ethical and Regulatory Issues
In a recent webinar, Dr. Luke Gelinas, IRB Chair at Advarra, provided a framework for evaluating offers of payment to research participants. In addition to outlining the challenging ethical and…
Protocol Feasibility to Promote Trial Efficiency
Scientific abstracts and articles have reported that 20-50% of studies do not accrue subjects at the site level (1-6). This contributes to a significant amount of waste in clinical research,…
Study Activation: A Complex Process That Doesn’t Have to Be Painful
Study activation data from the Forte community shows on average, it takes about six months to activate a new, interventional, treatment clinical trial. Long activation periods are not a new…